These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6202984)

  • 1. The ergoloid mesylate dihydroergotoxine: radioimmunoassay measurements on plasma and blood-pressure-lowering activity.
    Woodcock BG; Habedank WD; Loh W; Rietbrock N
    J Cardiovasc Pharmacol; 1984; 6(3):543-5. PubMed ID: 6202984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-dergocrine plasma concentrations and blood pressure changes in hypertensive patients during therapy with slow-release co-dergocrine mesylate.
    Woodcock BG; Herrmann W; Habedank WD
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):63-5. PubMed ID: 1551748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution.
    Luotola H
    Ann Clin Res; 1983; 15 Suppl 38():1-121. PubMed ID: 6367617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specificity and precision of a radioimmunoassay of dihydroergotoxine in plasma].
    Loh W; Woodcock BG
    Arzneimittelforschung; 1983; 33(4):568-70. PubMed ID: 6683536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between radioreceptor assay and radioimmunoassay for the determination of dihydroergotoxine in rabbit plasma samples.
    Shimada N; Ushioda K; Nagatsuka S; Ueda T; Yokoshima T
    J Immunol Methods; 1983 Dec; 65(1-2):191-8. PubMed ID: 6655239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroergotoxine kinetics in healthy men after intravenous and oral administration.
    Woodcock BG; Loh W; Habedank WD; Rietbrock N
    Clin Pharmacol Ther; 1982 Nov; 32(5):622-7. PubMed ID: 7128002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effects of physiological release of melatonin on arterial distensibility and blood pressure.
    Yildiz M; Akdemir O
    Cardiol Young; 2009 Apr; 19(2):198-203. PubMed ID: 19267945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years.
    Köberle S; Spiegel R
    Gerontology; 1984; 30 Suppl 1():3-52. PubMed ID: 6489764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans.
    Mercuro G; Rossetti ZL; Rivano CA; Ruscazio M; Tocco L; Gessa G; Cherchi A
    Hypertension; 1987 Jan; 9(1):35-40. PubMed ID: 3793199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation and comparison of body mass index on hemodynamics in hypertensive and normotensive patients undergoing intravenous sedation.
    Cillo JE; Finn R
    J Oral Maxillofac Surg; 2006 Apr; 64(4):583-8. PubMed ID: 16546636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular responses in hypertensive outpatients starting oral propranolol, determined from the brachial pulse upstroke.
    Carlisle R; Porter A; Raftery EB; Hill ID
    Eur J Cardiol; 1980; 12(1):63-72. PubMed ID: 7439235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of the changes in blood pressure and pulse rate of hypertensive patients during tooth extraction.
    Gungormus M; Buyukkurt MC
    Acta Med Austriaca; 2003; 30(5):127-9. PubMed ID: 15055158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the shapes of the oscillometric pulse amplitude envelopes and their characteristic ratios on the differences between auscultatory and oscillometric blood pressure measurements.
    Amoore JN; Vacher E; Murray IC; Mieke S; King ST; Smith FE; Murray A
    Blood Press Monit; 2007 Oct; 12(5):297-305. PubMed ID: 17890968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption kinetics of dihydroergotoxine following oral administration to man.
    Woodcock BG; Rietbrock N; Loh W; Habedank WD
    Br J Clin Pharmacol; 1985 Dec; 20(6):603-9. PubMed ID: 4091992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute changes in intracerebral vascular resistance after application of dihydrogenated ergot alkaloids (author's transl)].
    Vaupel P; Hutten H
    Arzneimittelforschung; 1980; 30(4):598-602. PubMed ID: 6772196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of angiotensin II on inflammation mediators in healthy subjects].
    Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R
    Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous beta-endorphins in hypertension: correlation with 24-hour ambulatory blood pressure.
    Guasti L; Cattaneo R; Daneri A; Bianchi L; Gaudio G; Regazzi MB; Grandi AM; Bertolini A; Restelli E; Venco A
    J Am Coll Cardiol; 1996 Nov; 28(5):1243-8. PubMed ID: 8890822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive and specific radioimmunoassays for dihydroergotoxine components in plasma.
    Collignon F; Pradelles P
    Eur J Nucl Med; 1984; 9(1):23-7. PubMed ID: 6421592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.